Herbert Fritsche has joined the scientific advisory board of Health Discovery, of Waco Texas. Fritsche is currently a professor of laboratory medicine and chief of the clinical chemistry section at The University of Texas, M.D. Anderson Cancer Center in Houston, where he has been a researcher for 35 years. Health Discovery is a discovery company that uses computational modeling to identify diagnostic and therapeutic targets.
James Mullen has been elected to the board of directors of PerkinElmer. Mullen is CEO of Biogen Idec. He was formerly chairman of the board and CEO of Biogen. He has also served at Biogen as president; director of facilities and engineering; vice president of operations; and vice president international. Prior to joining Biogen, Mullen had various positions at SmithKline Beecham. He holds a BS in chemical engineering from Rensselaer Polytechnic Institute and an MBA from Villanova University.